Evidence map›Paper›PMID 27439200›Full record

ArticleAllergy2016

Combining genomewide association study and lung eQTL analysis provides evidence for novel genes associated with asthma.

M A Nieuwenhuis, M Siedlinski, M van den Berge, R Granell, X Li, M Niens, P van der Vlies, J Altmüller, P Nürnberg, M Kerkhof and 16 more

Open access · greenAbstract read
In one paragraph

Article in Allergy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Copy Number Variation in Asthma: An Integrative Review.Clinical reviews in allergy & immunology · 2025
    Review
  6. Genetics of chronic respiratory disease.Nature reviews. Genetics · 2024
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Cholinergic neuroplasticity in asthma driven by TrkB signaling.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  19. Omics for the future in asthma.Seminars in immunopathology · 2020
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 11 institutions in 5 countries.

M A NieuwenhuisDepartment of Pulmonary Diseases, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
M SiedlinskiGroningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
M van den BergeDepartment of Pulmonary Diseases, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
R GranellSchool of Social and Community Medicine, University of Bristol, Bristol, UK.
X LiWake Forest School of Medicine, Center for Genomics and Personalized Medicine Research and the Section on Pulmonary, Critical Care, Allergy and Immunologic Disease, Winston-Salem, NC, USA.
M NiensDepartment of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
P van der VliesDepartment of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
J AltmüllerCologne Center for Genomics (CCG), Universität zu Köln, Köln, Germany.
P NürnbergCologne Center for Genomics (CCG), Universität zu Köln, Köln, Germany.
M KerkhofGroningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
O C van SchayckDepartment of General Practice, CAPHRI, MUMC+, Maastricht, the Netherlands.
R A RiemersmaGroningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
T van der MolenGroningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
J G de MonchyGroningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Y BosséDepartment of Molecular Medicine, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Québec, Canada.
A SandfordJames Hogg Research Laboratory, St Paul's Hospital, The University of British Columbia, Vancouver, Canada.
C A Bruijnzeel-KoomenDepartment of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, the Netherlands.
R Gerth van WijkDepartment of Allergology, Erasmus Medical Centre Rotterdam, Rotterdam, the Netherlands.
N H Ten HackenDepartment of Pulmonary Diseases, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
W TimensGroningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
H M BoezenGroningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
J HendersonSchool of Social and Community Medicine, University of Bristol, Bristol, UK.
M KabeschDepartment of Pediatric Pneumology and Allergy, University Children's Hospital Regensburg (KUNO), Regensburg, Germany.
J M VonkGroningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
D S PostmaDepartment of Pulmonary Diseases, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
G H KoppelmanGroningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
University Medical Center Groningen · NLUniversity of Groningen · NLUniversity of Bristol · GBUniversity of Cologne · DEErasmus University Rotterdam · NLMaastricht University Medical Centre · NLUniversité Laval · CAUniversity Hospital Regensburg · DEUniversity Medical Center Utrecht · NLUniversity of British Columbia · CAWake Forest University · US

Funding

Genome Wide Association for Asthma and Lung FunctionR01HL087665 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MEYERS, DEBORAH A. · 2007 to 2009
$7.7M
Genetic studies in difficult to treat asthma: TENORR01HL076285 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BLEECKER, EUGENE ROLAND · 2004 to 2007
$2.4M
CIHR MOP – 123369CIHR PPP – 130151Medical Research Council 74882Medical Research Council G0401540Medical Research Council G9815508NHLBI NIH HHS R01 HL076285NHLBI NIH HHS R01 HL087665Wellcome TrustWellcome Trust 076467
6 · The paper itself

Abstract

backgroundGenomewide association studies (GWASs) of asthma have identified single-nucleotide polymorphisms (SNPs) that modestly increase the risk for asthma. This could be due to phenotypic heterogeneity of asthma. Bronchial hyperresponsiveness (BHR) is a phenotypic hallmark of asthma. We aim to identify susceptibility genes for asthma combined with BHR and analyse the presence of cis-eQTLs among replicated SNPs. Secondly, we compare the genetic association of SNPs previously associated with (doctor's diagnosed) asthma to our GWAS of asthma with BHR.

methodsA GWAS was performed in 920 asthmatics with BHR and 980 controls. Top SNPs of our GWAS were analysed in four replication cohorts, and lung cis-eQTL analysis was performed on replicated SNPs. We investigated association of SNPs previously associated with asthma in our data.

resultsA total of 368 SNPs were followed up for replication. Six SNPs in genes encoding ABI3BP, NAF1, MICA and the 17q21 locus replicated in one or more cohorts, with one locus (17q21) achieving genomewide significance after meta-analysis. Five of 6 replicated SNPs regulated 35 gene transcripts in whole lung. Eight of 20 asthma-associated SNPs from previous GWAS were significantly associated with asthma and BHR. Three SNPs, in IL-33 and GSDMB, showed larger effect sizes in our data compared to published literature.

conclusionsCombining GWAS with subsequent lung eQTL analysis revealed disease-associated SNPs regulating lung mRNA expression levels of potential new asthma genes. Adding BHR to the asthma definition does not lead to an overall larger genetic effect size than analysing (doctor's diagnosed) asthma.

Indexed as

Genetic Predisposition to DiseaseGenome-Wide Association StudyQuantitative Trait LociAllelesAsthmaCase-Control StudiesChromosome MappingFemaleGenetic Association StudiesGenotypeHumansLungMaleMeta-Analysis as TopicNetherlandsPhenotypeasthmabronchial hyperresponsivenessgene expressiongeneticsgenomewide association studies

Identifiers

PMID27439200
PMCPMC5145001
OpenAlexW2493266901

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.